Crescent Capital BDC (NASDAQ:CCAP – Free Report) had its price objective lifted by Keefe, Bruyette & Woods from $18.50 to $19.00 in a research note issued to investors on Thursday, Marketbeat.com reports. They currently have an outperform rating on the stock. A number of other research analysts have also weighed in on CCAP. Wells Fargo […]